Increased levels of interleukin-12 in Plasmodium falciparum malaria:: correlation with the severity of disease

被引:47
作者
Malaguarnera, L
Imbesi, RM
Pignatelli, S
Simporè, J
Malaguarnera, M
Musumeci, S
机构
[1] Univ Sassari, Dept Pediat, I-07100 Sassari, Italy
[2] Univ Catania, Dept Biomed Sci, I-95124 Catania, Italy
[3] Ctr Med St Camille, Ouagadougou, Burkina Faso
[4] Univ Catania, Dept Internal Med, I-95124 Catania, Italy
[5] CNR, Inst Populat Genet, Alghero, Italy
关键词
IL-12; malaria; macrophage activation;
D O I
10.1046/j.1365-3024.2002.00478.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-12, produced by mononuclear phagocytes, activates the T-helper 1 (Th1) cells and helps, as a mediator, the innate immune response to intracellular microbes. In Plasmodium falciparum infection, this proinflammatory cytokine has immunoregulatory functions with effects on the immune response to the blood stage of disease, but also induces protection and reduces malarial anaemia. In this study, the levels of IL-12 were determined in 73 African children, aged 2-144 months (median 19.5 months), who had severe or mild P. falciparum malaria. IL-12 was determined using the enzyme-linked immunosorbent assay. The levels of IL-12 were found to be significantly elevated (21.6 +/- 18.3 pg/ml) in patients who suffered less severely from the disease. In contrast, the levels of IL-12 were found to be lower (13.1 +/- 7.11 pg/ml) in patients who suffered more severely from the disease.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 17 条
[1]   Interleukin-12 and malaria [J].
Crutcher, JM ;
Stevenson, MM ;
Sedegah, M ;
Hoffman, SL .
RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8) :552-559
[2]  
Doolan DL, 1999, J IMMUNOL, V163, P884
[3]  
Lee SH, 1997, THROMB HAEMOSTASIS, V77, P289
[4]   Low interleukin-12 activity in severe Plasmodium falciparum malaria [J].
Luty, AJF ;
Perkins, DJ ;
Lell, B ;
Schmidt-Ott, R ;
Lehman, LG ;
Luckner, D ;
Greve, B ;
Matousek, P ;
Herbich, K ;
Schmid, D ;
Weinberg, JB ;
Kremsner, PG .
INFECTION AND IMMUNITY, 2000, 68 (07) :3909-3915
[5]   MALARIA PATHOGENESIS [J].
MILLER, LH ;
GOOD, MF ;
MILON, G .
SCIENCE, 1994, 264 (5167) :1878-1883
[6]   Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection [J].
Mohan, K ;
Sam, H ;
Stevenson, MM .
INFECTION AND IMMUNITY, 1999, 67 (02) :513-519
[7]   The molecular basis of T helper 1 and T helper 2 cell differentiation [J].
O'Garra, A ;
Arai, N .
TRENDS IN CELL BIOLOGY, 2000, 10 (12) :542-550
[8]   Reduced interleukin-12 and transforming growth factor-ß1 in severe childhood malaria:: Relationship of cytokine balance with disease severity [J].
Perkins, DJ ;
Weinberg, JB ;
Kremsner, PG .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :988-992
[9]   ANEMIA OF PLASMODIUM-FALCIPARUM MALARIA [J].
PHILLIPS, RE ;
PASVOL, G .
BAILLIERES CLINICAL HAEMATOLOGY, 1992, 5 (02) :315-330
[10]   SIGNAL TRANSDUCTION IN HOST-CELLS BY A GLYCOSYLPHOSPHATIDYLINOSITOL TOXIN OF MALARIA PARASITES [J].
SCHOFIELD, L ;
HACKETT, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) :145-153